Figure 3.
Overallsurvival of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy (n = 238).

Overallsurvival of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy (n = 238).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal